podophyllotoxin has been researched along with stilbenes in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamel, E; Ho, HH; Lin, CM; Pettit, GR | 1 |
| Chu, PS; Dempcy, RO; Hamel, E; Lin, CM; Pettit, GR; Schmidt, JM; Singh, SB | 1 |
| Sackett, DL | 1 |
| D'Amato, RJ; Flynn, E; Hamel, E; Lin, CM | 1 |
| Day, BW; Hamel, E; Rosenkranz, HS; ter Haar, E | 1 |
| Kovar, P; Ng, SC; Rosenberg, SH; Tahir, SK | 1 |
| Chaudhuri, AR; Hausheer, FH; Ludueña, RF; Schwarz, PM; Seetharamalu, P | 1 |
| Gupta, MM; Khanuja, SP; Kumar, JK; Negi, AS; Srivastava, V | 1 |
| Burnett, JC; Day, BW; Gussio, R; Hamel, E; Hermone, AR; McGrath, C; Nguyen, TL; Wipf, P; Zaharevitz, DW | 1 |
| Chen, P; Hu, Z; Lewis, A; Li, C; Li, PK; Pandit, B; Rich, W; Sackett, DL; Schaefer, K; Sun, Y | 1 |
| Akhmanova, A; Doodhi, H; Kapitein, LC; Katrukha, EA; Meijering, E; Mohan, R; Smal, I; Steinmetz, MO | 1 |
| Nandagopal, K; Routh, S | 1 |
| Defant, A; Mancini, I | 1 |
3 review(s) available for podophyllotoxin and stilbenes
| Article | Year |
|---|---|
Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Binding Sites; Cell Division; Lignans; Podophyllotoxin; Polymers; Stilbenes; Structure-Activity Relationship; Tubulin | 1993 |
Plant-based anticancer molecules: a chemical and biological profile of some important leads.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Humans; Paclitaxel; Podophyllotoxin; Stilbenes | 2005 |
Patent Survey of Resveratrol, Taxol, Podophyllotoxin, Withanolides and Their Derivatives Used in Anticancer Therapy.
Topics: Humans; Neoplasms; Paclitaxel; Patents as Topic; Podophyllotoxin; Resveratrol; Stilbenes; Withanolides | 2017 |
10 other study(ies) available for podophyllotoxin and stilbenes
| Article | Year |
|---|---|
Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.
Topics: Animals; Bibenzyls; Binding Sites; Brain; Cattle; Colchicine; Guanosine Triphosphate; Kinetics; Macromolecular Substances; Mitosis; Models, Structural; Plant Extracts; Podophyllotoxin; Protein Binding; Stilbenes; Tropolone; Tubulin | 1989 |
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
Topics: Animals; Anisoles; Antineoplastic Agents; Bibenzyls; Binding Sites; Binding, Competitive; Colchicine; Leukemia L1210; Mice; Mitosis; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Tubulin | 1988 |
Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.
Topics: 2-Methoxyestradiol; Binding Sites; Colchicine; Estradiol; Glutamates; Kinetics; Microtubule-Associated Proteins; Microtubules; Podophyllotoxin; Polymers; Stilbenes; Tubulin | 1996 |
Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Binding Sites; Colchicine; Models, Molecular; Paclitaxel; Podophyllotoxin; Protein Conformation; Software; Stilbenes; Tubulin; Tubulin Modulators | 1996 |
Rapid colchicine competition-binding scintillation proximity assay using biotin-labeled tubulin.
Topics: Aminophenols; Bibenzyls; Binding Sites; Binding, Competitive; Biotinylation; Colchicine; Demecolcine; Mebendazole; Microspheres; Podophyllotoxin; Scintillation Counting; Solvents; Stilbenes; Streptavidin; Sulfonamides; Tritium; Tubulin; Yttrium | 2000 |
The interaction of the B-ring of colchicine with alpha-tubulin: a novel footprinting approach.
Topics: Amino Acid Sequence; Animals; Bibenzyls; Binding Sites; Cattle; Chromatography, High Pressure Liquid; Colchicine; Fluorescence; Models, Molecular; Molecular Sequence Data; Peptide Fragments; Podophyllotoxin; Protein Conformation; Protein Footprinting; Stilbenes; Tropolone; Tryptophan; Tubulin; Urea | 2000 |
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Topics: 2-Methoxyestradiol; 4-Butyrolactone; Aminophenols; Binding Sites; Chalcone; Colchicine; Cyclopropanes; Estradiol; Indans; Lignans; Models, Molecular; Molecular Structure; Nocodazole; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Sulfonamides; Thiazoles; Tubulin; Tubulin Modulators | 2005 |
Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; DNA, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Isomerism; Magnetic Resonance Spectroscopy; Molecular Conformation; Podophyllotoxin; Pyrroles; Stilbenes; Structure-Activity Relationship; Tubulin | 2006 |
End-binding proteins sensitize microtubules to the action of microtubule-targeting agents.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cellular Senescence; Colchicine; Depsipeptides; Green Fluorescent Proteins; HeLa Cells; Humans; Lactones; Microscopy, Fluorescence; Microtubule-Associated Proteins; Microtubules; Models, Biological; Paclitaxel; Podophyllotoxin; Statistics, Nonparametric; Stilbenes; Tubulin Modulators; Vinblastine | 2013 |
Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Naphthoquinones; Neoplasms; Podophyllotoxin; Pyridines; Quinolines; rho-Associated Kinases; Stilbenes; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tubulin; Tubulin Modulators | 2019 |